LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article ; Online: Age, CD34+ cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation.

    Regalado-Artamendi, Isabel / García-Fasanella, Marta / Medina, Laura / Fernandez-Sojo, Jesus / Esquirol, Albert / García-Cadenas, Irene / Martino, Rodrigo / Briones, Javier / Sierra, Jorge / Novelli, Silvana

    Vox sanguinis

    2023  Volume 118, Issue 8, Page(s) 681–689

    Abstract: Background and objectives: Autologous stem cell transplant (ASCT) is a widely used therapy for lymphoma patients and can nowadays be performed on an outpatient basis. This study aimed to describe transfusion support in lymphoma patients undergoing ASCT ... ...

    Abstract Background and objectives: Autologous stem cell transplant (ASCT) is a widely used therapy for lymphoma patients and can nowadays be performed on an outpatient basis. This study aimed to describe transfusion support in lymphoma patients undergoing ASCT and identify increased or prolonged transfusion requirement predictors.
    Materials and methods: A retrospective study of all consecutive lymphoma patients undergoing ASCT between 2010 and 2020.
    Results: Out of 226 patients, 145 (64%) received red blood cell (RBC) transfusions, whereas all 226 (100%) required platelet transfusion (PT). Transfusions between Day +1 and +30 were higher in patients over 60 (2 [1-4] vs. 2 [0-2] RBC; p = 0.001 and 4 [2-8] vs. 3 [2-4] PT; p < 0.001); patients with pre-transplant anaemia (4 [2.5-6] vs. 2 [0-2] RBC; p < 0.001 and 5 [3-9] vs. 3 [2-4] PT; p = 0.001); pre-transplant thrombocytopenia (2 [1-4] vs. 2 [0-2] RBC; p < 0.001 and 4 [3-8.5] vs. 2 [1-3] PT; p < 0.001) or CD34
    Conclusion: These four factors (age ≥60 years; BEAM conditioning, CD34
    MeSH term(s) Humans ; Middle Aged ; Hematopoietic Stem Cell Transplantation ; Retrospective Studies ; Transplantation, Autologous ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Lymphoma/therapy ; Lymphoma/etiology ; Stem Cell Transplantation ; Thrombocytopenia/etiology ; Anemia/therapy ; Anemia/etiology
    Language English
    Publishing date 2023-06-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 80313-3
    ISSN 1423-0410 ; 0042-9007
    ISSN (online) 1423-0410
    ISSN 0042-9007
    DOI 10.1111/vox.13486
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience.

    Fernandez-Sojo, Jesus / Delgadillo, Joaquim / Vives, Joaquim / Rodriguez, Luciano / Mendoza, Ana / Azqueta, Carmen / Garcia-Buendia, Ana / Valdivia, Elena / Martorell, Lluis / Rubio-Lopez, Nuria / Linares, Mónica / Alonso, Sofia / Ancochea, Agueda / García-Rey, Enric / García-Muñoz, Nadia / Medina, Laura / Querol, Sergio

    Cytotherapy

    2022  Volume 25, Issue 1, Page(s) 14–19

    Abstract: Background aims: To describe and analyze whether a hub-and-spoke organizational model could efficiently provide access to chimeric antigen receptor (CAR) T-cell therapy within a network of academic hospitals and address the growing demands of this ... ...

    Abstract Background aims: To describe and analyze whether a hub-and-spoke organizational model could efficiently provide access to chimeric antigen receptor (CAR) T-cell therapy within a network of academic hospitals and address the growing demands of this complex and specialized activity.
    Methods: The authors performed a retrospective evaluation of activity within the Catalan Blood and Tissue Bank network, which was established for hematopoietic stem cell transplantation to serve six CAR T-cell programs in academic hospitals of the Catalan Health Service. Procedures at six hospitals were followed from 2016 to 2021. Collection shipments of starting materials, CAR T-cell returns for storage and infusions for either clinical trials or commercial use were evaluated.
    Results: A total of 348 leukocytapheresis procedures were performed, 39% of which were delivered fresh and 61% of which were cryopreserved. The network was linked to seven advanced therapy medicinal product manufacturers. After production, 313 CAR T-cell products were shipped back to the central cryogenic medicine warehouse located in the hub. Of the units received, 90% were eventually administered to patients. A total of 281 patients were treated during this period, 45% in clinical trials and the rest with commercially available CAR T-cell therapies.
    Conclusions: A hub-and-spoke organizational model based on an existing hematopoietic stem cell transplantation program is efficient in incorporating CAR T-cell therapy into a public health hospital network. Rapid access and support of growing activity enabled 281 patients to receive CAR T cells during the study period.
    MeSH term(s) Humans ; Immunotherapy, Adoptive/methods ; Receptors, Chimeric Antigen ; Public Health ; Retrospective Studies ; Hematopoietic Stem Cell Transplantation ; Receptors, Antigen, T-Cell
    Chemical Substances Receptors, Chimeric Antigen ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2022-08-27
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2039821-9
    ISSN 1477-2566 ; 1465-3249
    ISSN (online) 1477-2566
    ISSN 1465-3249
    DOI 10.1016/j.jcyt.2022.07.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience.

    Fernandez-Sojo, Jesus / Valdivia, Elena / Esquirol, Albert / Portos, Jose-Manuel / Rovira, Montse / Suarez, Maria / Diaz-de-Heredia, Cristina / Uría, Maria-Luz / Ortí, Guillermo / Ferra, Christelle / Mussetti, Alberto / Paviglianiti, Annalisa / Marsal, Julia / Badell, Isabel / Lozano, Miquel / Gomez, David / Azqueta, Carmen / Martorell, Lluis / Rubio, Nuria /
    Garcia-Buendia, Ana / Villa, Juliana / Carreras, Enric / Querol, Sergio

    Vox sanguinis

    2023  Volume 118, Issue 9, Page(s) 783–789

    Abstract: Background and objectives: Bone marrow (BM) harvesting is one of the essential sources of stem cells for haematopoietic stem cell transplantation. In 2019, commercial BM collection kits became unavailable in Europe. Consequently, we created an in-house ... ...

    Abstract Background and objectives: Bone marrow (BM) harvesting is one of the essential sources of stem cells for haematopoietic stem cell transplantation. In 2019, commercial BM collection kits became unavailable in Europe. Consequently, we created an in-house BM collection kit as an alternative.
    Materials and methods: We compared two groups of BM collections. The first collections were taken using an in-house kit from June 2022 through February 2023 and the second with a commercial kit from February 2021 through May 2022. These all took place at seven collection centres (CC). We analysed the harvest quality (cell blood count, CD34+ cells, viability, potency and sterility), the incidents occurring with each kit and the time to neutrophil and platelet engraftment in recipients.
    Results: A total of 23 donors underwent BM harvesting with the in-house kit and 23 with the commercial one. Both cohorts were comparable regarding donor characteristics, CC and time to procedure. No statistical differences were found in harvest quality between the in-house and commercial kits. A new transfusion set was required in three BM harvests (13%) with the in-house kit because of filter clogging. The median time to neutrophil and platelet engraftment was 21 days for both cohorts and 29 days (in-house) and 33 days (commercial), p = 0.284, respectively.
    Conclusion: The in-house BM collection kit offers a real approach to solve the diminished supply of commercial kits. A higher risk of filter clogging was observed compared with commercial kits due to the lack of 850 and 500 μm filters.
    MeSH term(s) Humans ; Bone Marrow Transplantation/methods ; Bone Marrow ; Hematopoietic Stem Cell Transplantation ; Transplantation, Homologous ; Tissue Donors
    Language English
    Publishing date 2023-08-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 80313-3
    ISSN 1423-0410 ; 0042-9007
    ISSN (online) 1423-0410
    ISSN 0042-9007
    DOI 10.1111/vox.13499
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?

    Riveiro-Barciela, Mar / Muñoz-Couselo, Eva / Fernandez-Sojo, Jesús / Diaz-Mejia, Nely / Parra-López, Rafael / Buti, María

    Journal of hepatology

    2018  Volume 70, Issue 3, Page(s) 564–566

    MeSH term(s) Hepatitis ; Humans ; Immunotherapy ; Liver Failure, Acute ; Neoplasms ; Plasma Exchange
    Language English
    Publishing date 2018-11-28
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2018.10.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Hemólisis intravascular por Clostridium perfringens.

    Fernandez-Sojo, Jesús / Navarro, José Tomás / Vives-Polo, Susana / Juncà, Jordi

    Medicina clinica

    2014  Volume 142, Issue 1, Page(s) e1

    Title translation Clostridium perfringens-induced intravascular hemolysis.
    MeSH term(s) Aged ; Clostridium Infections/blood ; Clostridium perfringens ; Hemolysis ; Humans ; Male
    Language Spanish
    Publishing date 2014-01-07
    Publishing country Spain
    Document type Case Reports ; Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2013.05.031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Derrame pericárdico exudativo y oligoartritis en un paciente recién diagnosticado de síndrome mielodisplásico.

    Fernández-Sojo, Jesús / Vives, Susana / Oliveras Vilà, Teresa / Ribera, Josep Maria

    Medicina clinica

    2014  Volume 143, Issue 1, Page(s) 43–44

    Title translation Exudative pericardial effusion and oligoarthritis in a patient newly diagnosed with myelodysplastic syndrome.
    MeSH term(s) Anemia, Refractory, with Excess of Blasts/complications ; Anemia, Refractory, with Excess of Blasts/diagnosis ; Anemia, Refractory, with Excess of Blasts/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Arthritis/drug therapy ; Arthritis/etiology ; Azacitidine/therapeutic use ; Cytarabine/administration & dosage ; Disease Progression ; Etoposide/administration & dosage ; Fatal Outcome ; Hepatomegaly/etiology ; Humans ; Idarubicin/administration & dosage ; Immunosuppressive Agents/therapeutic use ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/etiology ; Male ; Middle Aged ; Pericardial Effusion/drug therapy ; Pericardial Effusion/etiology ; Pleural Effusion/drug therapy ; Pleural Effusion/etiology ; Serositis/drug therapy ; Serositis/etiology
    Chemical Substances Immunosuppressive Agents ; Cytarabine (04079A1RDZ) ; Etoposide (6PLQ3CP4P3) ; Azacitidine (M801H13NRU) ; Idarubicin (ZRP63D75JW)
    Language Spanish
    Publishing date 2014-07-07
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2013.09.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Estudio comparativo sobre la utilidad de la profilaxis antibacteriana con levofloxacino en pacientes receptores de un trasplante de progenitores hematopoyéticos.

    Fernandez Sojo, Jesús / Batlle Massana, Montserrat / Morgades, Mireia / Vives Polo, Susana / Quesada, María Dolores / Ribera Santasusana, Josep María

    Medicina clinica

    2016  Volume 146, Issue 1, Page(s) 16–19

    Abstract: Background: Bacterial infection remains a frequent complication in patients receiving a hematopoietic stem cell transplantation (HSCT). However, the impact of the antibacterial prophylaxis mortality in these patients is controversial.: Patients and ... ...

    Title translation Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation.
    Abstract Background: Bacterial infection remains a frequent complication in patients receiving a hematopoietic stem cell transplantation (HSCT). However, the impact of the antibacterial prophylaxis mortality in these patients is controversial.
    Patients and methods: Retrospective comparison of 2 consecutive groups of patients undergoing HSCT receiving (n=132) or not (n=107) antibacterial prophylaxis with levofloxacin.
    Results: 41% of patients receiving prophylaxis with levofloxacin had microbiologically documented infection (MDI) with bacteremia, compared with 40% of those not receiving levofloxacin. The frequency of gram-negative bacteremia was 11 and 38%, the resistance to levofloxacin was 39 and 14%, and the mortality was 8 and 7%, respectively.
    Conclusions: In our experience, the use of levofloxacin as prophylaxis in HSCT was associated with a lower frequency of gram-negative bacteremia but was not associated with a decreased rate of MDI and did not influence their outcome. In contrast, there was an increase in quinolone resistance in patients treated with levofloxacin.
    MeSH term(s) Adolescent ; Adult ; Aged ; Anti-Bacterial Agents/therapeutic use ; Antibiotic Prophylaxis ; Bacteremia/etiology ; Bacteremia/prevention & control ; Female ; Gram-Negative Bacterial Infections/etiology ; Gram-Negative Bacterial Infections/prevention & control ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Levofloxacin/therapeutic use ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Young Adult
    Chemical Substances Anti-Bacterial Agents ; Levofloxacin (6GNT3Y5LMF)
    Language Spanish
    Publishing date 2016-01-01
    Publishing country Spain
    Document type Comparative Study ; English Abstract ; Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2015.05.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.

    Fernandez-Sojo, Jesus / Cid, Joan / Azqueta, Carmen / Valdivia, Elena / Martorell, Lluis / Codinach, Margarita / Marsal, Julia / Mussetti, Alberto / Esquirol, Albert / Trabazo, Maria / Benitez, Maria Isabel / Ferra, Christelle / Fox, Maria Laura / Linares, Mónica / Alonso, Eva / García-Rey, Enric / García-Muñoz, Nadia / Medina, Laura / Castillo-Flores, Nerea /
    Vall-Llovera, Ferran / Garcia, Antoni / Pinacho, Asuncion / Talarn, Carme / Arroba, Jose Garcia / Coll, Rosa / Santos, Mireia / Valero, Oliver / Carreras, Enric / Lozano, Miquel / Querol, Sergio

    Bone marrow transplantation

    2022  Volume 57, Issue 8, Page(s) 1341–1343

    MeSH term(s) Antigens, CD34 ; Hematopoietic Stem Cell Transplantation ; Humans ; Lymphoma/therapy ; Peripheral Blood Stem Cell Transplantation ; Transplantation, Autologous
    Chemical Substances Antigens, CD34
    Language English
    Publishing date 2022-05-25
    Publishing country England
    Document type Letter
    ZDB-ID 632854-4
    ISSN 1476-5365 ; 0268-3369 ; 0951-3078
    ISSN (online) 1476-5365
    ISSN 0268-3369 ; 0951-3078
    DOI 10.1038/s41409-022-01722-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.

    Fernandez-Sojo, Jesus / Horton, Roger / Cid, Joan / Azqueta, Carmen / Garcia-Buendia, Ana / Valdivia, Elena / Martorell, Lluis / Rubio-Lopez, Nuria / Codinach, Margarita / Aran, Gemma / Marsal, Julia / Mussetti, Alberto / Martino, Rodrigo / Diaz-de-Heredia, Cristina / Ferra, Christelle / Valcarcel, David / Linares, Mónica / Ancochea, Agueda / García-Rey, Enric /
    García-Muñoz, Nadia / Medina, Laura / Carreras, Enric / Villa, Juliana / Lozano, Miquel / Gibson, Daniel / Querol, Sergio

    Bone marrow transplantation

    2022  Volume 57, Issue 10, Page(s) 1531–1538

    Abstract: Cryopreservation was recommended to ensure continuity in allogeneic hematopoietic progenitor cells (HPC) transplantation during the COVID-19 pandemic. Several groups have shown no impact on clinical outcomes for patients who underwent HPC transplantation ...

    Abstract Cryopreservation was recommended to ensure continuity in allogeneic hematopoietic progenitor cells (HPC) transplantation during the COVID-19 pandemic. Several groups have shown no impact on clinical outcomes for patients who underwent HPC transplantation with cryopreserved products during the first months of this pandemic. However, concerns about quality control attributes after cryopreservation have been raised. We investigated, in 155 allogeneic peripheral blood cryopreserved HPC, leukocytapheresis characteristics influencing viable CD34
    MeSH term(s) Antigens, CD34/analysis ; COVID-19 ; Cell Survival ; Cryopreservation ; Hematopoietic Stem Cell Transplantation ; Hematopoietic Stem Cells ; Humans ; Leukapheresis ; Pandemics
    Chemical Substances Antigens, CD34
    Language English
    Publishing date 2022-07-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 632854-4
    ISSN 1476-5365 ; 0268-3369 ; 0951-3078
    ISSN (online) 1476-5365
    ISSN 0268-3369 ; 0951-3078
    DOI 10.1038/s41409-022-01750-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.

    Grau-Expósito, Judith / Luque-Ballesteros, Laura / Navarro, Jordi / Curran, Adrian / Burgos, Joaquin / Ribera, Esteban / Torrella, Ariadna / Planas, Bibiana / Badía, Rosa / Martin-Castillo, Mario / Fernández-Sojo, Jesús / Genescà, Meritxell / Falcó, Vicenç / Buzon, Maria J

    PLoS pathogens

    2019  Volume 15, Issue 8, Page(s) e1007991

    Abstract: Latency reversal agents (LRAs) have proven to induce HIV-1 transcription in vivo but are ineffective at decreasing the size of the latent reservoir in antiretroviral treated patients. The capacity of the LRAs to perturb the viral reservoir present in ... ...

    Abstract Latency reversal agents (LRAs) have proven to induce HIV-1 transcription in vivo but are ineffective at decreasing the size of the latent reservoir in antiretroviral treated patients. The capacity of the LRAs to perturb the viral reservoir present in distinct subpopulations of cells is currently unknown. Here, using a new RNA FISH/flow ex vivo viral reactivation assay, we performed a comprehensive assessment of the viral reactivation capacity of different families of LRAs, and their combinations, in different CD4+ T cell subsets. We observed that a median of 16.28% of the whole HIV-reservoir induced HIV-1 transcripts after viral reactivation, but only 10.10% of these HIV-1 RNA+ cells produced the viral protein p24. Moreover, none of the LRAs were powerful enough to reactivate HIV-1 transcription in all CD4+ T cell subpopulations. For instance, the combination of Romidepsin and Ingenol was identified as the best combination of drugs at increasing the proportion of HIV-1 RNA+ cells, in most, but not all, CD4+ T cell subsets. Importantly, memory stem cells were identified as highly resistant to HIV-1 reactivation, and only the combination of Panobinostat and Bryostatin-1 significantly increased the number of cells transcribing HIV within this subset. Overall, our results validate the use of the RNA FISH/flow technique to assess the potency of LRAs among different CD4+ T cell subsets, manifest the intrinsic differences between cells that encompass the latent HIV reservoir, and highlight the difficulty to significantly impact the latent infection with the currently available drugs. Thus, our results have important implications for the rational design of therapies aimed at reversing HIV latency from diverse cellular reservoirs.
    MeSH term(s) Anti-HIV Agents/pharmacology ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/virology ; Depsipeptides/pharmacology ; Diterpenes/pharmacology ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/immunology ; Humans ; Viral Load ; Virus Activation/drug effects ; Virus Activation/immunology ; Virus Latency/drug effects ; Virus Latency/immunology
    Chemical Substances Anti-HIV Agents ; Depsipeptides ; Diterpenes ; romidepsin (CX3T89XQBK) ; ingenol (IC77UZI9G8)
    Language English
    Publishing date 2019-08-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1007991
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top